Phosphodiesterase 4 (PDE4) ACTOne Stable Cell Line
|
Catalog Number:
CL-03-PDE4
|
Price: Please inquire order@eEnzyme.com
Detailed Description
|
CL-03-PDE4
|
|
Name
|
Phosphodiesterase 4 (PDE4) ACTOne™ Stable Cell Line
|
|
Description
|
This cell line is a HEK293-CNG cell line that expresses recombinant human PDE4 (mainly 4B and 4D). HEK293-CNG cells express a modified CNG (Cyclic Nucleotide Gated) channel that opens in response to elevated intracellular cAMP levels and consequently results in ion flux and cell membrane depolarization.
|
|
Application
|
cAMP dependent human PDE4 cell-based assay;
Cell-based high-throughput screening of human PDE4 agonists/antagonists.
|
|
Size
|
1x 106 cells
|
|
Detection
|
FlexStation or Microplate reader
|
|
For Downloading
|
==>> DATA SHEET
|
About Phosphodiesterase 4 (PDE4) Stable Cell Line
Phosphodiesterase 4 (PDE4) is a member of the cyclic nucleotide phosphodiesterase family that specifically hydrolyzes cyclic adenosine monophosphate (cAMP) into inactive AMP, thereby regulating intracellular cAMP signaling pathways. PDE4 enzymes play critical roles in controlling cellular responses to hormones, neurotransmitters, inflammatory mediators, and G protein-coupled receptor (GPCR) activation. Through modulation of intracellular cAMP levels, PDE4 regulates numerous physiological processes including immune responses, inflammation, airway smooth muscle function, neuronal signaling, and cellular proliferation. Because dysregulated PDE4 activity has been implicated in inflammatory diseases, chronic obstructive pulmonary disease (COPD), asthma, psoriasis, neurological disorders, and other pathological conditions, PDE4 has become an important therapeutic target for drug discovery and pharmacological research.
eEnzyme's PDE4 Stable Cell Line provides a reliable and reproducible cellular platform for the functional evaluation of PDE4 activity and the discovery of PDE4-targeted therapeutics. The cell line enables quantitative assessment of PDE4 inhibitors, modulators, and signaling pathway regulators through measurement of intracellular cAMP responses. Researchers can utilize this cell line to characterize compound potency, determine inhibitory activity, investigate cAMP-mediated signaling pathways, and support lead optimization programs. The stable expression system ensures consistent assay performance, making it suitable for both routine pharmacological studies and high-throughput screening applications.
The PDE4 Stable Cell Line is compatible with cAMP-based functional assays, reporter gene assays, and other cell-based screening platforms. Its robust and reproducible performance enables researchers to investigate PDE4-mediated signaling mechanisms, identify novel anti-inflammatory compounds, and support therapeutic development programs targeting PDE4-associated diseases.
Applications of the PDE4 Stable Cell Line
• PDE4 inhibitor screening and characterization • cAMP signaling pathway studies • Drug discovery and lead optimization programs • Anti-inflammatory therapeutic development • Compound potency and efficacy determination • High-throughput screening applications • Cell signaling and pharmacological research • Functional characterization of PDE4 modulators
Biological Significance of PDE4
PDE4 is a cAMP-specific phosphodiesterase that serves as a key regulator of intracellular cyclic nucleotide signaling. By controlling the degradation of cAMP, PDE4 influences numerous downstream pathways including protein kinase A (PKA), CREB-mediated transcription, inflammatory signaling, and immune cell activation. Elevated PDE4 activity reduces intracellular cAMP levels and can contribute to inflammatory and immune-mediated responses, while inhibition of PDE4 increases cAMP signaling and often produces anti-inflammatory effects. This mechanism has led to the successful development of PDE4-targeted therapeutics for inflammatory and respiratory diseases. Because PDE4 plays a central role in regulating cAMP homeostasis and cellular signaling, it remains one of the most extensively studied phosphodiesterases in drug discovery, inflammation research, respiratory biology, and neuropharmacology.
|
|
|